首页 | 本学科首页   官方微博 | 高级检索  
检索        

胰岛素强化治疗对2型糖尿病患者血清脂联素的影响
引用本文:崔利娜,余婷婷,王椿,钟莉,张祥迅,龙洋,喻红玲,冉兴无.胰岛素强化治疗对2型糖尿病患者血清脂联素的影响[J].华西医学,2011(6):823-827.
作者姓名:崔利娜  余婷婷  王椿  钟莉  张祥迅  龙洋  喻红玲  冉兴无
作者单位:四川大学华西医院内分泌代谢科;成都市龙泉驿区第一人民医院内分泌科;四川大学华西医院内分泌代谢病实验室
摘    要:目的探讨胰岛素强化治疗对2型糖尿病(type 2diabetes mellitus,T2DM)患者血清脂联素(adiponectin,APN)的影响。方法 2007年7~12月,研究纳入连续使用胰岛素治疗至少3个月但血糖控制欠佳6.5%≤糖化血红蛋白(hemoglobin A1c,HbA1c)≤11.0%]的T2DM患者40例,其中男18例,女22例;年龄29~69岁;平均诊断T2DM病史11年。治疗方案为进行16周的胰岛素强化治疗,血糖控制目标为空腹血糖≤7mmol/L,餐后2h血糖≤8mmol/L。分别于强化治疗前、强化治疗4周后及强化治疗16周后测定HbA1c以及血清APN水平。结果与强化治疗前相比,胰岛素治疗4周后空腹及三餐后2h血糖明显下降(P〈0.05),但HbA1c和血清APN水平差异无统计学意义(P〉0.05);强化16周后,HbA1c水平明显低于治疗前和治疗4周后且差异具有统计学意义(P〈0.05),APN水平高于治疗前和治疗4周后且差异有统计学意义(P〈0.05)。体质量指数在强化治疗16周后明显增加且与强化治疗前和强化治疗后4周相比差异具有统计学意义(P〈0.05)。APN与空腹血糖(b=-0.225,P=0.013)、早餐后2h血糖(b=-0.229,P=0.012)呈负相关。结论胰岛素强化治疗可以提高T2DM患者血清APN水平。

关 键 词:2型糖尿病  脂联素  胰岛素强化治疗

Effect of Intensive Insulin Therapy on Serum Adiponectin Level in Type 2 Diabetic Patients
CUI Li-na,YU Ting-ting,WANG Chun,ZHONG Li,ZHANG Xiang-xun,LONG Yang,YU Hong-ling,RAN Xing-wu.Effect of Intensive Insulin Therapy on Serum Adiponectin Level in Type 2 Diabetic Patients[J].West China Medical Journal,2011(6):823-827.
Authors:CUI Li-na  YU Ting-ting  WANG Chun  ZHONG Li  ZHANG Xiang-xun  LONG Yang  YU Hong-ling  RAN Xing-wu
Institution:1.1.Department of Endoceinology and Metabolism,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,P.R.China;2.Department of Endoceinology,the First People’s Hospital of Longquanyi District,Chengdu,Sichuan 610100,P.R.China;3.Laboratory of Endoceinology and Metabolism,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,P.R.China
Abstract:Objective To investigate the effect of intensive insulin therapy on serum adiponectin(APN) level in patients with type 2 diabetes mellitus(T2DM).Methods Forty patients with T2DM who had undergone insulin therapy for at least three months but with their blood glucose poorly controlled glycosylated hemoglobin Alc(HbA1c) level ranged from 6.5% to 10.0%] from July to December 2007 were enrolled in this study.There were 18 males and 22 females with their age ranged from 29 to 69 years.They had an average time of T2DM history of 11 years.Intensive insulin therapy was carried out for 16 weeks with a target of less than 7 mmol/L for fasting blood glucose and 8 mmol/L for postprandial blood glucose.HbA1c and serum adiponectin concentrations were detected at baseline,at week 4 after intensive therapy and at the end of the study.Results After 4 weeks of intensive blood glucose control,fasting and postprandial blood glucose levels decreased significantly(P0.05),but the HbA1c and serum APN concentrations did not reduce remarkably(P0.05).After 16 weeks of treatment,the level of HbA1c was significantly lower than those at baseline and 4 weeks after treatment(P0.05),and serum APN concentration increased significantly(P0.05),compared with those two time points.However,an evident increase of body mass index(BMI) was found while compared with BMI at baseline and 4 weeks after treatment(P0.05).The linear regression analysis indicated that APN was negatively associated with fasting blood glucose(b=-0.225,P=(0.013)) and blood glucose level 2 hours after breakfast(b=-0.229,P=0.012).Conclusion Intensive insulin therapy can improve serum adiponectin level in type-2 diabetic patients.
Keywords:Type 2 diabetes mellitus  Adiponectin  Intensive insulin therapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号